Balance Sheet
Accumulated ExpensesAssetsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Liabilities and Shareholders Equity: 2015-2025

Historic Liabilities and Shareholders Equity for HUTCHMED (China) (HCM) over the last 2 years, with Jun 2025 value amounting to $1.8 billion.

  • HUTCHMED (China)'s Liabilities and Shareholders Equity rose 40.85% to $1.8 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $5.4 billion, marking a year-over-year increase of 12.16%. This contributed to the annual value of $1.0 billion for FY2022, which is 25.00% down from last year.
  • As of Q2 2025, HUTCHMED (China)'s Liabilities and Shareholders Equity stood at $1.8 billion, which was up 40.85% from $1.3 billion recorded in Q2 2024.
  • Over the past 5 years, HUTCHMED (China)'s Liabilities and Shareholders Equity peaked at $1.8 billion during Q2 2025, and registered a low of $693.1 million during Q1 2021.
  • In the last 3 years, HUTCHMED (China)'s Liabilities and Shareholders Equity had a median value of $1.3 billion in 2023 and averaged $1.4 billion.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first soared by 142.20% in 2021, then fell by 25.00% in 2022.
  • HUTCHMED (China)'s Liabilities and Shareholders Equity (Quarterly) stood at $1.4 billion in 2021, then declined by 25.00% to $1.0 billion in 2022, then grew by 8.64% to $1.3 billion in 2023, then declined by 2.82% to $1.3 billion in 2024, then spiked by 40.85% to $1.8 billion in 2025.
  • Its Liabilities and Shareholders Equity was $1.8 billion in Q2 2025, compared to $1.3 billion in Q2 2024 and $1.3 billion in Q2 2023.